| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017723260 |
| P356 | DOI | 10.1097/01.WCB.0000091765.61714.30 |
| P698 | PubMed publication ID | 14663336 |
| P50 | author | Ji Hoe Heo | Q60891638 |
| Jacinta Lucero | Q88745272 | ||
| P2093 | author name string | Gregory J del Zoppo | |
| Andrew P Mazar | |||
| Naohisa Hosomi | |||
| Takeo Abumiya | |||
| Dae-Il Chang | |||
| P2860 | cites work | Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family | Q24310476 |
| A matrix metalloproteinase expressed on the surface of invasive tumour cells | Q24312733 | ||
| Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes | Q24532196 | ||
| Disruption of epithelial cell-matrix interactions induces apoptosis | Q24673611 | ||
| cDNA Sequence and mRNA Tissue Distribution of a Novel Human Matrix Metalloproteinase with a Potential Transmembrane Segment | Q28115693 | ||
| Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia | Q28261750 | ||
| Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain | Q28307087 | ||
| Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate | Q28618372 | ||
| Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease | Q28618841 | ||
| Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor | Q28647054 | ||
| Detection of vitronectin mRNA in tissues and cells of the mouse | Q33267878 | ||
| Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. | Q33843796 | ||
| Tissue cooperation in a proteolytic cascade activating human interstitial collagenase | Q33849932 | ||
| Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. | Q33886514 | ||
| Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones | Q34182120 | ||
| Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion | Q36670336 | ||
| Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells | Q36676242 | ||
| Expression of the activation marker urokinase plasminogen-activator receptor in cultured human central nervous system microglia | Q36827290 | ||
| Peptide-derived antagonists of the urokinase receptor. affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation | Q38296358 | ||
| Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor | Q40865891 | ||
| Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor | Q40868535 | ||
| The urokinase-type plasminogen activator system in cancer metastasis: A review | Q41522331 | ||
| Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator | Q41600847 | ||
| Matrix metalloproteinases increase very early during experimental focal cerebral ischemia | Q41671816 | ||
| Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction | Q41689199 | ||
| Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia | Q41689204 | ||
| Brain injury and cerebrovascular fibrin deposition correlate with reduced antithrombotic brain capillary functions in a hypertensive stroke model | Q41747276 | ||
| Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity | Q41827841 | ||
| Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices | Q42113244 | ||
| Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion | Q42505289 | ||
| Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury | Q42506689 | ||
| Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation | Q42519680 | ||
| Expression of membrane-type matrix metalloproteinase in rabbit neointimal tissue and its correlation with matrix-metalloproteinase-2 activation | Q48040095 | ||
| Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors | Q48091109 | ||
| Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice | Q48144666 | ||
| Experimental acute thrombotic stroke in baboons | Q48278183 | ||
| Urokinase-type plasminogen activator expression by neurons and oligodendrocytes during process outgrowth in developing rat brain | Q48278639 | ||
| Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues | Q48362679 | ||
| Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain | Q48384389 | ||
| Microglia isolated from rat brain secrete a urokinase-type plasminogen activator | Q48492439 | ||
| Cerebral infarction. Evolution of histopathological changes after occlusion of a middle cerebral artery in primates | Q48546405 | ||
| DNA scission after focal brain ischemia. Temporal differences in two species | Q48698063 | ||
| Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness | Q48747558 | ||
| Synthesis of urokinase-type plasminogen activator and of type-1 plasminogen activator inhibitor in neuronal cultures of human fetal brain: stimulation by phorbol ester | Q48868563 | ||
| Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures | Q48973809 | ||
| Histologic assessment of neurons in rat models of cerebral ischemia | Q49113976 | ||
| Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. | Q49133201 | ||
| Developmental transition in plasticity properties of differentiating astrocytes: age-related biochemical profile of plasminogen activators in astroglial cultures. | Q52243464 | ||
| White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues. | Q53210682 | ||
| The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis | Q57584744 | ||
| P433 | issue | 12 | |
| P921 | main subject | cerebral infarction | Q1209150 |
| P304 | page(s) | 1408-1419 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
| P1476 | title | Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia | |
| P478 | volume | 23 |
| Q37553275 | 2-Chloroethanol Induced Upregulation of Matrix Metalloproteinase-2 in Primary Cultured Rat Astrocytes Via MAPK Signal Pathways |
| Q35240865 | Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence |
| Q27026843 | Aging and the neurovascular unit |
| Q35777502 | Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke |
| Q46044860 | Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB. |
| Q64250415 | Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus |
| Q36644315 | Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. |
| Q36351793 | Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke |
| Q46110252 | Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke |
| Q33842161 | Hemostasis and alterations of the central nervous system |
| Q34937315 | Hypoxia-ischemia or excitotoxin-induced tissue plasminogen activator- dependent gelatinase activation in mice neonate brain microvessels |
| Q36684162 | Immunologic privilege in the central nervous system and the blood-brain barrier |
| Q26766038 | Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke |
| Q37281874 | Inflammation and the neurovascular unit in the setting of focal cerebral ischemia |
| Q34319977 | Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia |
| Q30414848 | Inhibition of MMP-2 but not MMP-9 influences inner ear spiral ganglion neurons in vitro |
| Q46150981 | Involvement of matrix metalloproteinases-2 and -9 in the formation of a lacuna-like cerebral cavity |
| Q35056901 | Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases |
| Q48535582 | Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines |
| Q34170971 | Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement |
| Q48468454 | Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. |
| Q37962503 | Matrix metalloproteinases and small artery remodeling |
| Q38444452 | Matrix metalloproteinases as therapeutic targets for stroke |
| Q40028510 | Matrix metalloproteinases in cerebral ischemia |
| Q38151704 | Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders |
| Q35939162 | Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation. |
| Q45240483 | Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice |
| Q33823616 | Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator |
| Q37810004 | Morphology and Properties of Brain Endothelial Cells |
| Q36104645 | Multiple roles for MMPs and TIMPs in cerebral ischemia |
| Q38247950 | Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms |
| Q41362038 | New approach to identify ischemic stroke patients at risk to develop hemorrhagic transformation. |
| Q34018715 | Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis? |
| Q47119067 | Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat. |
| Q48131341 | Protective effect of ginsenoside Rb1 on integrity of blood-brain barrier following cerebral ischemia |
| Q34038281 | Relationship of neurovascular elements to neuron injury during ischemia |
| Q37800133 | Review: Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury |
| Q100437398 | SerpinA3N deficiency deteriorates impairments of learning and memory in mice following hippocampal stab injury |
| Q38318458 | Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches |
| Q41654070 | Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles |
| Q38030379 | Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury |
| Q43799003 | The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model |
| Q37286882 | The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability |
| Q37696584 | The neurovascular unit in the setting of stroke |
| Q35990775 | The neurovascular unit, matrix proteases, and innate inflammation |
| Q36986793 | The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent |
| Q48017362 | The vascular basement membrane in the healthy and pathological brain. |
| Q35923428 | Tissue plasminogen activator and glial function |
| Q90446099 | Triticum vulgare Extract Modulates Protein-Kinase B and Matrix Metalloproteinases 9 Protein Expression in BV-2 Cells: Bioactivity on Inflammatory Pathway Associated with Molecular Mechanism Wound Healing |
| Q49021460 | Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia |
| Q37264260 | Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia. |
| Q37223437 | Virchow's triad: the vascular basis of cerebral injury |
Search more.